Bladder Cancer Career Development Award supports junior investigators' translational, clinical and epidemiological research to build independent programs and bring new concepts into clinical practice.
The 2026 award cycle is now closed; applications were previously listed as due October 26, 2026, at 5:00 PM ET. BCAN says to check back for updates on the 2027 cycle and has removed the application link and 2026 guidelines.
Funder: Bladder Cancer Advocacy Network
Due Dates (Anticipated): October 2027 (Patient advocate support request) | October 2027 (Application)
Funding Amounts: $250,000 over three years
Summary: Supports junior investigators developing independent bladder cancer research programs through translational, clinical, or epidemiological research.
Key Information: Applicants cannot have held major independent research funding or currently hold an active NIH K-level award or equivalent.
The Bladder Cancer Advocacy Network (BCAN) Career Development Award helps junior faculty establish independent bladder cancer research programs, including research on upper tract disease. It bridges mentored funding and independent research support, with the goal of positioning recipients to compete successfully for an NIH R01 or equivalent after the award. It is not intended to supplement investigators who are already independently funded.
The award supports translational, clinical—including clinical trials—and epidemiological research directly relevant to bladder cancer. Projects must demonstrate potential to translate new concepts into clinical practice, with measurable outcomes and milestones achievable during the three-year grant period. BCAN welcomes research across the disease spectrum, giving particular consideration to scientifically meritorious proposals aligned with its priorities in diagnostics, therapeutics, patient-centered care, and population health and epidemiology.